Home > Products
Cat. No. Product name CAS No.
DCC4832 Sodelglitazar

PPARdelta receptor agonist

447406-78-2
DCC4833 Sodium Dehydrocholate

Hepatoprotective and choleretic agent

145-41-5
DCC4834 Sodium Oxybate

Narcolepsy agent, being used to treat catalepse and daytime sleepiness in patients with narcolepsy

502-85-2
DCC4835 Solanidine

Natural tumor antagonistic steroidal alkaloid, inducing typical cellular apoptotic hallmarks and cell cycle blockage at S-G2/M phase, activating nuclear import of DFF-40 mediated nucleosomal disruption and cell demise

80-78-4
DCC4836 Solimastat

Novel oral, broad-spectrum matrix metalloproteinase inhibitor (MMPI), being >10-fold more active than marimastat in inhibiting the processing of cell-bound TNF-alpha

226072-63-5
DCC4837 Somapacitan

Novel long-acting, reversible albumin-binding growth hormone (GH) derivative for treatment of growth hormone dificiency

1338578-34-9
DCC4838 Somatoprim

Unique somatostatin receptor subtypes 2-, 4- and 5-selective analogue, effectively reducing GH secretion in human GH-secreting pituitary adenomas even in Octreotide non-responsive tumours.

252845-37-7
DCC4839 Somcl-668

Novel potent and selective allosteric modulator of sigma-1 receptor

DCC4840 Somcl-863

Novel, selective and orally bioavailable c-Met inhibitor, exhibiting antitumor activity both in vitro and in vivo

1452310-87-0
DCC4841 Sonedenoson

A2A adenosine receptor agonist

131865-88-8
DCC4842 Sophoradin

Natural analgesic, antipyretic, anti-inflammatory, and anti-tumor agent

23057-54-7
DCC4843 Sophorafavanone A

Inhibitor of constitutive and inducible STAT3 activation through the activation of SHP-2 tyrosine phosphatase

87893-18-3
DCC4844 Sophoraflavanone B

Natural inhibitor of the Kv1.3 channels in a concentration-dependent manner

68682-02-0
DCC4845 soraphinol A

Human norepinephrine transporter blocker

1006373-58-5
DCC4846 sori-20041

DAT modulator, being unique in affecting substrate uptake without impacting efflux

488082-05-9
DCC4847 sori-9804

Novel partial inhibitor of amphetamine-induced dopamine release

434326-29-1
DCC4848 Sortin3 Maleate

Sorting inhibitor, blocking Vps16 function, one protein in the class C tethering complex, and increasing aflatoxin synthesis and export

DCC4849 Spam (signal Peptide-based Affinity Maturated Ligand)

Novel Programmed Death Ligand 1 (PD-L1) Binding Peptide (a Peptide Ligand for PD-L1)

DCC4850 spb03924

Novel telomerase inhibitor

263766-82-1
DCC4851 SPB08007

0

DCC4852 Spd-2-am

Novel photo-controllable hydrogen sulfide donor applicable in live cells

DCC4853 Spectinamide-1599

Novel anti-tuberculosis agent against intracellular Mycobacterium tuberculosis

DCC4854 Spectinomycin Dihydrochloride

Antibiotic, binding to the bacterial 30S ribosomal subunit, interfering with the initiation of protein synthesis and with proper protein elongation and leading to bacterial cell death

21736-83-4
DCC4855 Spi-1865

Novel gamma-secretase modulator

DCC4856 Spirohydantoin-21

Novel selective orally bioavailable inhibitor of p300/CBP histone acetyltransferase

DCC4857 Spirooxindole 1a

Novel p53 Stabilizer for Brain Cell Differentiation

DCC4858 Spiroxamine

Sterol Biosynthesis Inhibitor, Fungicide

118134-30-8
DCC4859 Spla2 Inhibitor Pyr-1

Novel potent sPLA2 inhibitor, selectively targeting hGIIA and hGIID

DCC4860 Spmtrien

Novel isosteric charge-deficient spermine analogue

DCC4861 spongiacidin C

USP7 inhibitor from the marine sponge Stylissa massa

193202-57-2
DCC4862 Spongosine

Pivotal intercellular signal transmitter

24723-77-1
DCC4863 Spop-in-6lc

Novel SPOP inhibitor, suppressing the viability and inhibiting the colony formation of ccRCC cell lines driven by cytoplasmic SPOP

2136270-56-7
DCC4864 Spt-in-1

Novel potent serine palmitoyl transferase (SPT) inhibitor

1933533-18-6
DCC4865 Sptssb-binder-18

Novel potent and selective binder of small subunit B of the serine palmitoyltransferase complex (SPTSSB)

DCC4866 Spu-106

Novel specific PAK4 inhibitor, effectively inhibiting the invasion of SGC7901 cells without cytotoxicity, regulating the PAK4/LIMK1/cofilin and PAK4/SCG10 signaling pathways

713080-84-3
DCC4867 Sr-01000634273-1

Novel inhibitor of the in vivo aggregation of

882277-05-6
DCC4868 Sr10098

Novel NR4A nuclear receptor modulator

850705-30-5
DCC4869 Sr10658

Novel NR4A nuclear receptor modulator

DCC4870 Sr142948a

Selective neurotensin antagonist

184162-64-9
DCC4871 Sr-17398 Hydrochloride

Novel Unc-51-Like Kinase 1 (ULK1)

1585928-95-5
DCC4872 Sr2067

Novel partial agonist of PPARgamma

DCC4873 Sr24237

Novel NR4A nuclear receptor modulator

1167623-24-6
DCC4874 Sr-3737

Potent inhibitor of both JNK3 and p38

1164153-37-0
DCC4875 Sr-4326

Novel Inhibitor of c-Jun N-terminal Kinase 3 (JNK3)

1164153-25-6
DCC4876 Sr-43845

Novel renin inhibitor

114037-60-4
DCC4877 Sr-58611a

The first selective β3 adrenergic agonist, showing to possess a profile of antidepressant activity in rodents

121524-09-2
DCC4878 Sr8185

Novel Selective TBK1/IKK dual inhibitor with anticancer potency

DCC4879 Srctide

Peptide substrate for many protein kinases, such as Blk, BTK, cKit, EPHA1, EPHB2, EPHB3, ERBB4, FAK, Flt3, IGF-1R, ITK, Lck, MET, MUSK, Ret, Src, TIE2, TrkB, VEGF-R1 (Flt-1) and VEGF-R2 (KDR)

DCC4880 Srebp-in-dhg

Novel inhibitor of sterol regulatory element-binding protein (SREBP), impairing the SREBP activity by inhibiting glucose transporters and thereby activating AMP-activated protein kinase (AMPK)

DCC4881 Sri-22138

Novel mixed μ opioid receptor (MOR) agonist and δ/κ opioid receptor (DOR/KOR) antagonist

DCC4882 Sri-29132

Highly blood-brain barrier permeant, potent, and selective for LRRK2 kinase activity, being effective in attenuating pro-inflammatory responses in macrophages and rescuing neurite retraction phenotypes in neurons.

1482305-44-1
DCC4883 Sri-31040

Potent DAT allosteric modulator, partially inhibiting DAT uptake without altering DAT-mediated reverse transport and with minimal inhibition of DAT binding

1928715-72-3
DCC4884 Sri-35241

Novel inhibitor of thrombospondin 1 activation of TGF-β, blocking TGF-β activation (pIC50 = 8.12 nM) and has a plasma half life of 1.8 h (iv)

2307429-54-3
DCC4885 Sri-36160

Novel potent inhibitor of Wn/ß-catenin signaling in cancer cells

2085682-66-0
DCC4886 Sri-37683

Novel GLUT inhibitor, preferentially inhibiting the growth of GBM cells with minimal toxicity to non-neoplastic astrocytes and neurons, also inhibiting glucose uptake and decrease the glycolytic capacity and glycolytic reserve capacity of GBM patient-deri

DCC4887 Sri-37684

Novel GLUT inhibitor, preferentially inhibiting the growth of GBM cells with minimal toxicity to non-neoplastic astrocytes and neurons, also inhibiting glucose uptake and decrease the glycolytic capacity and glycolytic reserve capacity of GBM patient-deri

DCC4888 Sri-39067

Novel MOR agonist/DOR antagonist that produced systemically active potent antinociceptive activity in tail-flick assay in mice

DCC4889 Srt3025

Novel Sirtuin1 Activator, Down-Regulating Sclerostin and Rescuing Ovariectomy-Induced Bone Loss

1231952-55-8
DCC4890 Srt3025 Hydrochloride

Novel potent SIRT1 activator

2070015-26-6
DCC4891 Srt3190 (2s,3r)

Novel selective CXCR2 antagonist

1204707-73-2
DCC4892 Srta-in-i

Novel potent inhibitor of Staphylococcus aureus sortase A (SrtA)

DCC4893 Ss1020

Novel antiestrogen, lacking estrogenic and genotoxic actions

DCC4894 SS-amyloid-in-7l

Potent ß-amyloid aggregation inhibitor; Antioxidant

DCC4895 SS-carboline-1-carboxylic Acid

Potent competitive inhibitor of indoleamine 2,3-dioxygenase (IDO)

26052-96-0
DCC4896 SS-cit

Non-selective potent dopamine reuptake inhibitor

135416-43-2
DCC4897 SS-cit Tartrate

Non-selective potent dopamine reuptake inhibitor

133647-95-7
DCC4898 SS-elemene

Novel inhibitor of Pak1 activation, anti-cancer ingredient isolated from the Chinese traditional herb Curcuma wenyujin

33880-83-0
DCC4899 SS-hydroxymethyl Chalcone

The first selective inhibitor of Histone Deacetylase 2 (HDAC2)

1613310-15-8
DCC4900 Ssj-183

Novel antimalarial agent

1187533-34-1
DCC4901 SS-lysine

Elongation factor P (EF-P) fuction modifier

4299-56-3
DCC4902 Ssm3 Tfa Salt

Potent furin inhibitor, blocking furin-dependent cell surface processing of anthrax protective antigen-83 in vitro.

922732-52-3
DCC4903 SS-nf-atra

Novel chimeric degrader against cellular retinoic acid binding proteins (CRABPs), inducing the AhR-dependent degradation of CRABP-1 and CRABP-2 via the ubiquitin-proteasome pathway

DCC4904 SS-nf-jq1

Novel chimeric degrader against bromodomain-containing (BRD) proteins, inducing the interaction of AhR and BRD proteins and displaying effective anticancer activity that correlated with protein knockdown activity

DCC4905 SS-nicotinamide Adenine Dinucleotide, Reduced Disodium

Cofactor for mitochondrial deacetylase sirtuin-3 enzyme, regulating energy metabolism and immunity and modulating inflammasome assembly

606-68-8
DCC4906 Ssr126768a

Novel Selective and Orally Active Oxytocin Receptor Antagonist for the Prevention of Preterm Labor

785048-28-4
DCC4907 Ssr180575 Featured

SSR-180,575 is a drug which acts as a selective agonist at the peripheral benzodiazepine receptor, also known as the mitochondrial 18 kDa translocator protein or TSPO. It has been shown to have neuroprotective and cardioprotective effects and to stimulate steroidogenesis of pregnenolone in the brain, which may be linked to its neuroprotective action.

220448-02-2
DCC4908 SS-thujaplicinol

Inhibitor of the replication of herpes simplex viruses 1 and 2 (HSV-1 and HSV-2)

4356-35-8
DCC4909 Sstr3-agonist-5c

Novel non-peptidic highly potent somatostatin receptor 3 (SSTR3) agonist

DCC4910 Sstr3-antagonist-3a

Novel potent sstr3 antagonist, showing to reduce glucose excursion in a mouse oGTT assay

DCC4911 Sstr5a

Novel somatostatin receptor subtype 5 antagonist, stimulating glucoseinduced GLP-1 secretion, reducing blood glucose in a gut- and GLP-1R-dependent manner

DCC4912 St026567

Novel potent mast cell (MC) activator, promoting de novo synthesis of cytokines and inducing the release of eicosanoids from human and mouse MCs

5067-25-4
DCC4913 St029248

Novel potent mast cell (MC) activator, promoting de novo synthesis of cytokines and inducing the release of eicosanoids from human and mouse MCs

96-69-5
DCC4914 St056083

Novel inhibitor of the c-di-AMP synthetase DNA integrity scanning protein (DisA) in vitro

299419-24-2
DCC4915 St101036

Novel potent mast cell (MC) activator, promoting de novo synthesis of cytokines and inducing the release of eicosanoids from human and mouse MCs

1018143-39-9
DCC4916 st-1032

Novel histamine H3 receptor ligand

DCC4917 St1237

Potent, direct, non-cytotoxic Arachidonate_5-lipoxygenase>5-lipoxygenase (5-LO) inhibitor

1380593-17-8
DCC4918 St-161

Antiviral agent against LASV and a number of other viruses in the Arenaviridae family

DCC4919 St-1703

Novel histamine H3 receptor ligand

DCC4920 St-1892

Novel highly potent and soluble partial FXR agonist

1409411-32-0
DCC4921 St-198

Seletive dopamine D3 receptors

854924-64-4
DCC4922 St-1992

Novel potent A 1 R/A 2A R/H 3 R multitargeting ligand (MTL)

DCC4923 St-2001

Novel potent A 1 R/A 2A R/H 3 R multitargeting ligand (MTL)

DCC4924 St-2262

Novel selective NaV1.7 inhibitor, blocking the extracellular vestibule of the channel with an IC50 of 72 nM and greater than 200-fold selectivity over off-target sodium channel isoforms, NaV1.1-1.6 and NaV1.8

DCC4925 St4070

Highly selective FAAH>fatty acid amide hydrolase (FAAH) inhibitor

1186236-75-8
DCC4926 St7710aa1

Novel PARP-1 inhibitor, showing significant in vitro target inhibition and capability to substantially bypass the multidrug resistance mediated by Pgp

1542067-20-8
DCC4927 Sta-9584

Novel tubulin-binding vascular disrupting agent (VDA)

906481-23-0
DCC4928 Stad-2

Cell permeable AKAP disruptor, selectively binding to PKA-RII and blocking the interaction of PKA-RI with AKAP

1542100-77-5
DCC4929 Stalobacin I

Novel Lipopeptide Antibiotic with Potent Antibacterial Activity against Multidrug-Resistant Bacteria

DCC4930 Stanozolol [10418-03-8]

Anabolic-androgenic steroid (AAS), acting as an agonist of the androgen receptor (AR)

10418-03-8
DCC4931 Stat3 -in-11

Novel STAT3 inhibitor, selectively inhibiting STAT3 phosphorylation and exhibiting potent antitumor activity

DCC4932 stat3 Inhibitor 6

Novel inhibitor of STAT3 signaling pathway

665014-97-1
DCC4933 Stat3-in-13r

Novel inhibitor of STAT3, targeting SH2 domain

DCC4934 Stat3-in-3

Novel potent and selective inhibitor of STAT3

2361304-26-7
DCC4935 Stat3-in-a69

Novel inhibitor targeting the DNA-binding domain of STAT3, suppressing tumor growth, metastasis and STAT3 target gene expression in vivo

1164546-70-6
DCC4936 Stat3-in-b9

Novel inhibitor of signal transducer and activator of transcription 3 (STAT3), inhibiting the proliferation of tumor cells harboring abnormal activation of STAT3, such as, MDA-MB-468, MDA-MB-231 and DU145

825611-06-1
DCC4937 Stat5a-in-27

Novel cell-permeable selective STAT5a inhibitor prodrug, inhibiting tyrosine phosphorylation of STAT5a with selectivity over STAT5b in cultured human leukemia cells, and representing a valuable tool to define the non-redundant molecular functions of the t

DCC4938 Stat5b-in-6a

Highly Potent and Selective Inhibitor of the Transcription Factor STAT5b

DCC4939 Stemazole

Novel human stem/progenitor cells proliferation activator, promoting survival and preserving stemness in human embryonic stem cells

317337-07-8
DCC4940 Sterigmatocystin

Natural inducer of G1 arrest in primary human esophageal epithelial cells but G2 arrest in immortalized cells

10048-13-2
DCC4941 Stf-038533

Novel inhibitor of expression from canonical CREB response element-containing promoters

423744-59-6
DCC4942 Stg -001

Novel RBP4 antagonist for treatment of Stargardt disease

DCC4943 Stictic Acid

Natural anti-feline infectious peritonitis virus (FIPV) agent, specifically targeting the 3CLpro of FIPV and inhibiting its replication

549-06-4
DCC4944 Sting Agonist 11

Novel non-nucleotide STING agonist, demonstrating antitumor activity when dosed intratumorally in a syngeneic mouse model

DCC4945 Sting Inhibitor C-171

Novel covalent antagonist of hsSTING

DCC4946 Stk-15

Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor

844651-66-7
DCC4947 Stk-22

Novel Fatty Acid Binding Protein 5 (FABP5) Inhibitor

843629-43-6
DCC4948 Stk295900

Dual inhibitor of topoisomerase 1 and 2, inducing G(2) arrest in the absence of DNA damage. Inhibitor of Plasmodium falciparum W2 (drug-resistant) proliferation in erythrocyte-based infection assay

4402-17-9
DCC4949 Stk508411

Novel inhibitor of the heterogeneous ribonuclear protein A18 (hnRNP A18)

664968-32-5
DCC4950 Stk630921

Novel blocker of IL-17A binding to the IL-17A receptor (IL-17RA)

1033850-63-3
DCC4951 Stk683963

Novel activator of cellular ATG4B activity

370073-65-7
DCC4952 Stock1n-65837

Potent natural modulator of human Toll-like receptor 7 (TLR7)

DCC4953 Streptolidine

Metablite of the Streptomyces antibiotics streptothricin and streptolin

29307-61-7
DCC4954 Streptozocin

Antibiotic, being used as an antineoplastic agent and to induce diabetes in experimental animals

18883-66-4
DCC4955 Sts-e412

The first nonpeptidyl, selective activator of the tissue-protective EPOR/CD131 receptor

1609980-39-3
DCC4956 Sts-e424

Novel agonist of the tissue-protective erythropoietin (EPO) receptor, increasing FXN expression and EPOR phosphorylation

DCC4957 Stx-2622

Inhibitor of 17β-hydroxysteroid dehydrogenases (17β-HSDs)

37075-05-1
DCC4958 Stx2845

Novel Nonsteroidal Inhibitor of Carbonic Anhydrase IX

1623785-66-9
DCC4959 Su0383

Novel dual Inhibitor of repair enzymes 8-oxoguanine DNA glycosylase (OGG1) and human MutT Homolog 1 (NUDT1 or MTH1), increasing sensitivity of tumor cells to oxidative stress

DCC4960 Su11272

Novel potent c-MET inhibitor

669764-16-3
DCC4961 Su11606

Potent c-MET inhibitor

669764-17-4
DCC4962 Su11652

Sunitinib analog, acting as a potential inhibitor for nucleoside diphosphate kinase (NDK) from Leishmania major (LmNDK)

326914-10-7
DCC4963 Su-200

Agonist of TRPV1

184003-14-3
DCC4964 Su9518

Novel potent and selective inhibitor of the cellular PDGF receptor kinase and PDGF receptor-induced cell proliferation

251356-32-8
DCC4965 Subglutinol A

Natural immunosuppressive agent, effectively blocking T cell proliferation and survival while profoundly inhibiting pro-inflammatory IFNγ and IL-17 production by fully differentiated effector Th1 and Th17 cells, also acting as an estrogen receptor antagon

DCC4966 Suc-leu-leu-val-tyr-amc

Fluorescent substrate which can be hydrolyzed by the proteasome to release free AMC and the fluorescence of which is proportional to the proteasome activity

94367-21-2
DCC4967 Sucnr1-in-20

Novel antagonist of G-protein-coupled receptor SUCNR1 (succinate receptor 1 or GPR91)

DCC4968 Suku-33

Novel potent inhibitor of osteoclastogenesis, suppressing both equilibrative nucleoside transporters and concentrative nucleoside transporters

DCC4969 Sul-121 Hydrochloride

Novel inhibitor of airway inflammation and hyperresponsiveness in experimental models of chronic obstructive pulmonary disease (COPD)

1541170-25-5
DCC4970 Sulfacetamide

Antibacterial, inhibiting bacterial folic acid synthesis by competing with para amino benzoic acid

114-80-9
DCC4971 Sulfazecin

β-Lactam antibiotic against multi-drug resistant pathogens

77912-79-9
DCC4972 Sulfonyl Quinoxaline 1

Novel inhibitor of RhoG-hepcidin uptake

338394-53-9
DCC4973 Sulfosuccinimidyl Oleate Sodium

Neuroprotective agent, alleviating stroke-induced neuroinflammation

135661-44-8
DCC4974 Suloctidil Hydrochloride

Peripheral vasodilator

54767-71-4
DCC4975 Sulukast

Novel, potent, selective, and competitive antagonist of LTD4 and LTE4

98116-53-1
DCC4976 Sumanirole

D2 selective dopamine agonist, showing anxiolytic and anti-parkinsonian activities

179386-43-7
DCC4977 Sun13837

Novel fibroblast growth factor receptor modulator for treating neurodegenerative diseases

DCC4978 Sun-c5174

5-HT2 antagonist

191592-36-6
DCC4979 Supradamal

Potent Inhibitor of Plasmodium FK506 Binding Protein 35 (FKBD35), also act as a HIV inhibitor

71458-51-0
DCC4980 suvanine

Antagonist of the mammalian bile acid sensor farnesoid-X-receptor (FXR)

94203-53-9
DCC4981 Sv-293

Selective D2 dopamine receptor antagonist

873445-73-9
DCC4982 Sv-iii-130s

D2 dopamine receptor partial agonist in adenylyl cyclase inhibition assay and antagonist in the GIRK and phospho ERK1/2 assays

129722-23-2
DCC4983 Sw208108

Novel clickable tumor-specific irreversible inhibitor of stearoyl CoA desaturase (SCD)

1673557-43-1
DCC4984 Swainsonine

Natural potent alpha-mannosidase inhibitor, exhibiting antimetastatic, antiproliferative, and immunomodulatory activities

72741-87-8
DCC4985 swertisin

Potent differentiating agent

6991-10-2
DCC4986 S-y048

Novel selective OXE receptor antagonist

DCC4987 Sy-5609

Novel highly potent and selective CDK7 inhibitor, demonstrating broad anti-tumor activity in vivo

DCC4988 Syk-524

Novel universal opioid receptor agonist

DCC4989 Syk-in-ii

Novel inhibitor of the Syk kinase (spleen tyrosine kinase)

1345458-66-3
DCC4990 Syn-1 Peptide

Novel potent and specific inhibitor of syncytin-mediated cell fusion, completely blocking cell fusion at 1.6 μg/ml

DCC4991 Syn-1 Scr Peptide

Negative control of Syn-1 peptide, having the same amino acid composition as Syn-1 peptide, but a scrambled sequence

DCC4992 syn22269076

Novel Mycobacterium tuberculosis growth inhibitor

1214506-05-4
DCC4993 Synstab A

Novel microtubule-stablizer

257612-36-5
DCC4994 Synthalin Dihydrochloride

K+ channel blocker

301-15-5
DCC4995 Szu101

Novel TLR7 agonist via immune response induction and tumor microenvironment modulation

DCC4996 Szv558

Potent inhibitor of both rodent and human MAO-B, proved to be safe in high doses with no hERG and mutagenic activities and demonstrated neuroprotection in an in vivo chronic model of PD

1648929-13-8
DCC4997 T0511-4424

Novel COX-2 inhibitor

882215-85-2
DCC4998 T-0632

Potent and selective CCKA receptor antagonist

169042-78-8
DCC4999 T-10106

Novel potent PPARγ antagonist with much improved drug-like properties and promising pharmacokinetic profile

DCC5000 T16a(inh)-b01

Selective class B inhibitor of the Ca -activated Cl- Channel, Ano1(TMEM16A)

708246-07-5
DCC5001 T16a(inh)-d01

Selective class D inhibitor of the Ca -activated Cl- Channel, Ano1(TMEM16A)

874129-53-0
DCC5002 T-2 Toxin Triol

Type-A trichothecene mycotoxin

97373-21-2
DCC5003 T3ss Inhibitor Iii-7

Novel inhibitor of the type III secretion system (T3SS), acting as a anti-microbial agent against Xanthomonas oryzae pv. oryzae (Xoo)

DCC5004 t5660136

Novel Inhibitor of Adenovirus Gene Transfer

920852-86-4
DCC5005 t5660138

Novel Inhibitor of Adenovirus Gene Transfer

920882-18-4
DCC5006 T5975164

Inhibitor of HIV-1 Assembly that Targets the Phosphatidylinositol (4,5)-bisphosphate Binding Site of the HIV-1 Matrix Protein

949860-27-9
DCC5007 T6603185

Novel inhibitor of the catalytic functions of peroxiredoxin (Prx) and thioredoxin (Trx) systems

1208822-03-0
DCC5008 Tachioside

Natural radical scavenger on ABTS

109194-60-7
DCC5009 Tachyplegina

Novel Inhibitor of Parasite Motility and Invasion

331839-29-3
DCC5010 Tachyplegina-2

Novel Inhibitor of Parasite Motility and Invasion

296798-88-4
DCC5011 Tachyplegina-4

Novel Irriversible Inhibitor of Parasite Motility and Invasion

DCC5012 Tacrine-pyrimidone Hybrid 27g

Novel Potent Dual AChE/GSK-3 Inhibitor for the Treatment of Alzheimers Disease

DCC5013 Tah-19

Novel potent p53-MDM2/X antagonist, inhibiting MDM2 potently with a Ki value of 58 nmol/L, inducing accumulation of p53, p21 and MDM2, inhibiting cell cycle progression of U-2 OS cells at G1 phase in a p53-dependent manner

DCC5014 Ta-in-2

Novel inhibitor of the Klebsiella pneumoniae VapBC toxin-antitoxin (TA) system, acting as antimicrobial agents by disrupting the VapBC complex and activating VapC

DCC5015 Tak-137

Novel AMPA receptor potentiator with little agonistic effect, producing antidepressant-like effect without causing psychotomimetic effects

1358749-55-9
DCC5016 tak-187

Long-lasting ergosterol biosynthesis inhibitor

155432-64-7
DCC5017 Tak-21d

Potent FAAH Inhibitor

1143578-94-2
DCC5018 Tak-220 Hydrochloride

Novel anti-HIV CCR5 antagonist

674782-27-5
DCC5019 Tak-233

Novel selective 5-hydroxytryptamine type 2C (5-HT2C) receptor agonist

DCC5020 Tak-418

Novel inhibitor of the epigenetic modulator lysine-specific demethylase 1A (LSD1)

1818252-53-7
DCC5021 Talaroconvolutin A

Natural ferroptosis inducer, killing colorectal cancer cells in vitro and in vivo

273199-42-1
DCC5022 Talarozole

CYP26 inhibitor, potentiating the effects of all-trans retinoic acid on cultured human epidermal keratinocytes

201410-53-9
DCC5023 Talaumidin

Natural neurotrophic agent, promoting neurite outgrowth from neurons through PI3K/Akt pathway

DCC5024 Talirine

Novel Antibody-Drug Conjugate PBD Dimer Payload

1342820-51-2
DCC5025 Taltirelin

Superagonist at the human thyrotropin-releasing hormone receptor, reversing opioid-induced respiratory depression in isoflurane anesthetized rats

103300-74-9
DCC5026 Tamra-edatp

Novel Fluorescent dATP for DNA Synthesis In Vivo, exhibited high brightness, low toxicity, and rapid incorporation and depletion kinetics in both a vertebrate (zebrafish) and a nematode (Caenorhabditis elegans)

DCC5027 Tan-67

Potent and selective non-peptide δ1 opioid receptor agonist

148545-09-9
DCC5028 Tanshinol Borneol Ester

Novel angiogenesis stimulator, promoting multiple key steps of angiogenesis parially via Akt and MAPK signalling pathways, showing anti-ischemic and anti-atherosclerosis activities, also acting as a putative PPARγ agonist

DCC5029 Tap1a-opt1

Novel potent Na V -targeting peptide, exhibiting significant increased potency for Na V 1.1, Na V 1.2, Na V 1.3, Na V 1.6 and Na V 1.7 involved in several neurological disorders including acute and chronic pain, motor neuron disease and epilepsy

DCC5030 Tap1a-opt2

Novel potent Na V -targeting peptide, exhibiting significant increased potency for Na V 1.1, Na V 1.2, Na V 1.3, Na V 1.6 and Na V 1.7 involved in several neurological disorders including acute and chronic pain, motor neuron disease and epilepsy

DCC5031 Tapi-2 Acetate

ADAM-17 (TACE) and MMP inhibitor, sensitizing cancer stem cells to the lethal effects of 5-FU and blocking shedding of TNF-α from cell membranes

689284-12-6
<Prev1...190191192193194...215Next>